^
    CANCER:

    Small Intestinal Carcinoma

    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab
    Sensitive
    :
    A1
    NTRK3 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    gemcitabine + docetaxel
    Sensitive
    :
    A2
    NTRK1 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    gemcitabine + albumin-bound paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    LV5FU2
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab + ipilimumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab + ipilimumab
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    FOLFOX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    CAPOX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    bevacizumab
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    capecitabine
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    irinotecan
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    FOLFIRI
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    albumin-bound paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    docetaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    paclitaxel + gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    carboplatin + paclitaxel
    Sensitive
    :
    A2
    NTRK1 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK3 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    GTX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    FOLFIRINOX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    mFOLFOX6
    Sensitive
    :
    A2
    MSI-L/dMMR
    Small Intestinal Carcinoma
    dostarlimab
    Sensitive
    :
    A2
    RET fusion
    Small Intestinal Carcinoma
    selpercatinib
    Sensitive
    :
    C1
    PTEN mutation + MSI-H/dMMR
    Small Intestinal Carcinoma
    PD1 inhibitor
    Resistant
    :
    C3
    MSI-H/dMMR + TMB-L
    Small Intestinal Carcinoma
    PD1 inhibitor
    Resistant
    :
    C3